Search This Blog

Monday, July 29, 2019

Rhythm Pharmaceuticals EPS misses by $0.36

Rhythm Pharmaceuticals (NASDAQ:RYTM): Q2 GAAP EPS of -$1.24 misses by $0.36.
Cash, cash equivalents and short-term investments of $195.2M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)